Table 4.
Genotypic Frequencies of TNF-α (-308) and TNF-β (+ 252), Genotype and Estrogen Receptor Status, Progesterone Receptor status, Herception Receptor Status
| Genotype | Total (n=150) (%) | Estrogen Receptor Positive (n=67) (%) | Estrogen Receptor Negative (n=83) (%) | p value | OR(95%CI) |
|---|---|---|---|---|---|
| TNF-α (-308) (rs1800629G>A) | |||||
| GG | 68 (45.3) | 28 (41.7) | 40 (48.1) | 0.5099 | 0.77 (0.40-1.47) |
| GA | 73 (48.6) | 34 (50.7) | 39 (46.9) | 0.7428 | 1.16(0.61-2.21) |
| AA | 9 (6.0) | 5 (7.4) | 4 (4.8) | 0.5137 | 1.59(0.41-6.18) |
| TNF-β (+252) (rs361525 A>G) | |||||
| AA | 86 (57.3) | 38 (56.7) | 48 (57.9) | 1 | 0.95(0.49-1.83) |
| AG | 56 (37.4) | 27 (40.3) | 29 (34.9) | 0.6107 | 1.25 (0.64-2.44) |
| GG | 8 (5.3) | 2 (3.0) | 6 (7.2) | 0.2987 | 0.39 (0.07-2.02) |
| Genotype | Total (n=150) (%) | Progesterone Receptor Positive (n=71) (%) | Progesterone Receptor Negative (n=79) (%) | p value | OR(95%CI) |
| TNF-α (-308) (rs1800629G>A) | |||||
| GG | 68 (45.3) | 36 (50.7) | 32 (40.5) | 0.2511 | 1.51 (0.79-2.88) |
| GA | 73 (48.6) | 31 (43.6) | 42 (53.1) | 0.2571 | 0.68 (0.35-1.30) |
| AA | 9 (6.0) | 4 (5.6) | 5 (6.3) | 1 | 0.88 (0.22-3.42) |
| TNF-β (+252) (rs361525 A>G) | |||||
| AA | 86 (57.3) | 45 (63.4) | 41 (52.0) | 0.1868 | 1.60 (0.83-3.08) |
| AG | 56 (37.4) | 23 (32.4) | 33 (41.7) | 0.2432 | 0.66 (0.34-1.30) |
| GG | 8 (5.3) | 3 (4.2) | 5 (6.3) | 0.7223 | 0.65 (0.15-2.83) |
| Genotype | Total (n=150) (%) | Herceptin Receptor Positive (n=82) (%) | Herceptin Receptor Negative (n=68) (%) | p value | OR (95%CI) |
| TNF-α (-308) (rs1800629G>A) | |||||
| GG | 68 (45.3) | 37 (45.1) | 31 (45.5) | 1 | 0.98 (0.51-1.87) |
| GA | 73 (48.6) | 41 (50) | 32 (47.0) | 0.7451 | 1.12 (0.59-2.14) |
| AA | 9 (6.0) | 4 (4.9) | 5 (7.3) | 0.7321 | 0.64 (0.16-2.50) |
| TNF-β (+252) (rs361525 A>G) | |||||
| AA | 86 (57.3) | 49 (59.8) | 37 (54.4) | 0.6191 | 1.24 (0.64-2.38) |
| AG | 56 (37.4) | 28 (34.1) | 28 (41.2) | 0.4005 | 0.74 (0.38-1.44) |
| GG | 8 (5.3) | 5 (6.1) | 3 (4.4) | 0.7291 | 1.40 (0.32-6.11) |